Annotation Detail
Information
- Associated Genes
- CDKN2A
- Associated Variants
-
rs10811474
CDKN2A c.150+459T>C ( ENST00000304494.10, ENST00000494262.5, ENST00000498124.1, ENST00000498628.6, ENST00000530628.2, ENST00000579122.1, ENST00000579755.2 )
rs10511729
LINGO2 c.-35-18736G>A ( ENST00000379992.6, ENST00000698399.1, ENST00000698400.1, ENST00000698401.1, ENST00000698402.1, ENST00000698403.1 )
rs10811474
CDKN2A c.150+459T>C ( ENST00000304494.10, ENST00000494262.5, ENST00000498124.1, ENST00000498628.6, ENST00000530628.2, ENST00000579122.1, ENST00000579755.2 )
rs10511729
LINGO2 c.-35-18736G>A ( ENST00000379992.6, ENST00000698399.1, ENST00000698400.1, ENST00000698401.1, ENST00000698402.1, ENST00000698403.1 ) - Associated Disease
- Carcinoma of bladder
- Source Database
- DisGeNET
- Description
- ASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).
- Pubmed
- 25239644
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.0154721867085773
- Year of publication
- 2015
Drugs